CFDE Data Portal | Search RPS17P2

	Label	Description
	RPS17P2 associations Collection (Entity type)	Associations for RPS17P2_associations
	RPS17P2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RPS17P2 Gene (Entity type)	ENSG00000197575 - ribosomal protein S17 pseudogene 2
	GSE115542 digoxin 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE236502 paclitaxel 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE181517 doxorubicin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE196035 GSE196037 MEN1 inhibition 3 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

RPS17P2 associations

Associations for RPS17P2_associations

RPS17P2 associations.tsv

A file from IDG as part of the Harmonizome project

RPS17P2

ENSG00000197575 - ribosomal protein S17 pseudogene 2

GSE115542 digoxin 2 v 0 human up

A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human up

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human dn

A Gene Set from LINCS

GSE236502 paclitaxel 2 v 3 human up

A Gene Set from LINCS

GSE238018 MXRA8 knockout MDA-MB-231 3 v 2 human dn

A Gene Set from LINCS

GSE181517 doxorubicin 0 v 1 human up

A Gene Set from LINCS

GSE196035 GSE196037 MEN1 inhibition 3 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.